Caris Life Sciences Inc (CAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2013 | 12-2012 | 12-2011 | 12-2010 | 12-2009 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,741 | 17,671 | 14,078 | 14,393 | 14,492 |
| Receivables | 51,872 | 51,758 | 45,435 | 40,370 | 33,365 |
| Income taxes - deferred | N/A | 2,189 | 1,968 | 1,931 | 1,669 |
| Other current assets | 18,551 | 11,544 | 6,343 | 5,312 | 10,776 |
| TOTAL | $130,967 | $95,114 | $74,903 | $68,651 | $63,379 |
| Non-Current Assets | |||||
| PPE Net | 1,466,482 | 1,212,081 | 843,942 | 533,322 | 299,775 |
| Investments And Advances | 68,210 | 74,929 | 31,591 | 7,886 | 5,844 |
| Intangibles | 677 | 1,441 | 2,333 | 3,593 | 5,085 |
| Other Non-Current Assets | 9,253 | 4,376 | 599 | 0 | 0 |
| TOTAL | $1,544,622 | $1,292,827 | $878,465 | $544,801 | $310,704 |
| Total Assets | $1,675,589 | $1,387,941 | $953,368 | $613,452 | $374,083 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 74,080 | 61,044 | 25,764 | 24,800 | 800 |
| Accounts payable and accrued liabilities | 67,998 | 27,135 | 36,950 | 113,791 | 25,975 |
| Accrued Expenses | 6,230 | 8,465 | 5,761 | 5,408 | 3,638 |
| TOTAL | $157,091 | $106,779 | $79,053 | $154,161 | $38,451 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,058,628 | 888,990 | 575,014 | 220,800 | 161,500 |
| Deferred Revenues | 6,862 | 7,893 | 6,786 | 5,724 | 4,225 |
| Other Non-Current Liabilities | -594 | -816 | -625 | 181 | 0 |
| TOTAL | $1,103,372 | $934,317 | $625,579 | $261,617 | $206,534 |
| Total Liabilities | $1,260,463 | $1,041,096 | $704,632 | $415,778 | $244,985 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,241 | 22,055 | 19,295 | 19,295 | 17,917 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | 232,623 | 168,697 | 105,232 | 55,043 | 26,660 |
| Other shareholders' equity | -1,762 | -2,917 | 15,319 | 15,565 | -1,248 |
| TOTAL | $415,126 | $346,845 | $248,736 | $197,674 | $129,098 |
| Total Liabilities And Equity | $1,675,589 | $1,387,941 | $953,368 | $613,452 | $374,083 |